Global STD Diagnostics Market, By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing), Testing (Laboratory Devices, Point of Care Devices), Testing Devices (Thermal Cyclers, PCR, Lateral Flow Readers - Immunochromatographic Assays, Flow Cytometers, Differential Light Scattering Machines, Absorbance Microplate Reader, Phone Chips, Rapid Diagnostic Kits), End-User (Hospitals, Others) – Industry Trends and Forecast to 2030.
STD Diagnostics Market Analysis and Size
The rise in the rate of government initiatives, increasing number of technologically advanced products in the field of diagnostics, providing more precise testing results and growing population having multiple casual sex partners are the major factors driving the global STD diagnostics market. The preference of technologically advanced product range including diagnostic kits, instruments and reagents over traditional laboratory testing and introduction of government reforms targeted towards the betterment of healthcare infrastructure accelerate the global STD diagnostics market growth.
Data Bridge Market Research analyses that the global STD diagnostics market which was USD 9,190 million in 2022, and is expected to reach USD 17,636.26 million by 2030, and is expected to undergo a CAGR of 8.70% during the forecast period of 2023 to 2030. “Hospitals” dominates the end-user segment of the global STD diagnostics market owing to the increasing cases in hospitals. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
STD Diagnostics Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing), Testing (Laboratory Devices, Point of Care Devices), Testing Devices (Thermal Cyclers, PCR, Lateral Flow Readers - Immunochromatographic Assays, Flow Cytometers, Differential Light Scattering Machines, Absorbance Microplate Reader, Phone Chips, Rapid Diagnostic Kits), and End-User (Hospitals, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), BD (U.S.), Biocartis (Belgium), bioMérieux SA (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cepheid (U.S.), Danaher (U.S.), DiaSorin (Italy) , GenMark Diagnostics, Inc. (U.S.), Hologic Inc. (U.S.), OraSure Technologies, Inc. (U.S.), Qualigen Inc(U.S.), Quidel Corporation(U.S.), F. Hoffmann-La Roche Ltd(U.S.), Thermo Fisher Scientific Inc(U.S.), MedMira Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
STD means sexually transmitted diseases which are also called venereal diseases (VD) and are usually spread through the use of unsterilized drug needles, from mother to infant during childbirth or breast-feeding, blood transfusions and sexually. These diseases are detected through various tests as blood tests, urine samples or fluid samples and do not display any symptoms. With the help of antibiotics and antiviral drugs, STD caused by bacteria can be treated. Some of the devices used to diagnose the disease are absorbance microplate reader, flow cytometers, scattering machines and immunochromatographic assays among others.
Global STD Diagnostics Market Dynamics
Drivers
- Increase in the Incidence of STD Diseases
The rise in incidence of STD diseases and availability of effective product of the companies involved in research and development of STD diagnostics accelerate the market growth. The rising disease burden is primarily driving the STD diagnostics industry, which results by a significant margin in the rise of STD diagnostics usage.
According to the Global Progress Report 2021, the total number of new cases of HIV was 1.7 million in 2020. In addition, 156 million new cases of Trichomonas vaginalis infection, 128 million new cases of Chlamydia trachomatis infection, 82 million new cases of Neisseria gonorrhea, and 7.1 million new cases of Treponema pallidum were recorded in 2020. The number of new cases of HBV and HCV was around 1.5 million in 2019.
- Rise in Rapid and Early Diagnosis of STDs
HIV continues to be a major public health issue, globally. The purpose of screening is to identify people in an apparently healthy population who are at higher risk of a health problem or a condition so that an early treatment or intervention can be provided and thereby reduce the incidence and mortality rate within the population. For instance, in March 2022, National Chlamydia Screening Program (NCSP) was organized in the U.K.. The main aim of the program is to reduce the risk of untreated chlamydia infection. This program also focused on reducing the time to test results and treatment and re-testing after treatment
According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.
- Growing awareness regarding the disease and treatment
Growing awareness levels amongst patients and physicians pertaining to the applications is presumed to be contributing toward market growth. The aforementioned factor is believed to boost the adoption for a wide range of products which is expected to boost global STD diagnostics market over the forecast period of 2023 to 2030. Thus, an increase in product approvals for addressing the high demand for diagnosis of STDs may contribute to the growth of respective consumables in the market.
Increase in patient awareness through education campaigns, and growing government initiatives are anticipated to drive market growth. The report published by the World Health Organization in November 2021, reported that more than 1.0 million sexually transmitted infections are acquired globally and most of them are asymptomatic.
Opportunities
- Rising demand for advanced technologies
Furthermore, the rising demand for advanced technologies also boost up the market growth which will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.The space has the presence of advanced technology such as multiplex PCR products and next-generation HIV testing kits. Development and commercialization of such products enable the diagnosis of a wide range of STIs with appropriate treatment. Rising healthcare expenditure in developing countries which will further contribute by generating immense opportunities that will further expand the market's growth rate in the future.
In addition, advancements in STD diagnostics and research and development in developing new technologies are projected to fuel the market growth. Thus, the market is witnessing a major shift from conventional technologies to molecular diagnostics for the diagnosis of STD's is the major breakthrough for the growth of the market.
Restraints/Challenges
- High cost of devices
On the other hand, high cost associated with the advanced diagnostic devices and the implementation of stringent regulatory policies is expected to obstruct the STD diagnostics market growth in the above mentioned projected timeframe. Moreover, the social stigma around visiting the clinics regarding sexual diseases is projected to challenge the STD diagnostics market in the forecast period of 2023-2030.
This global STD diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global STD diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May 2022, Abbott’s Alinity m STI Assay received FDA clearance. It is a multiplex test that can detect and differentiate four common STDs simultaneously—Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV)
Global STD Diagnostics Market Scope
The global STD diagnostics market is segmented on the basis of type, testing, testing devices and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Chlamydia Testing
- Syphilis Testing
- Gonorrhea Testing
- Herpes Simplex Virus Testing
- Human Papilloma Virus Testing
- Human Immunodeficiency Virus Testing
Testing
- Laboratory Devices
- Point of Care Devices
Testing Devices
- Thermal Cyclers
- PCR
- Lateral Flow Readers - Immunochromatographic Assays
- Flow Cytometers
- Differential Light Scattering Machines
- Absorbance Microplate Reader
- Phone Chips
- Rapid Diagnostic Kits
End-User
- Hospitals
- Others
Global STD Diagnostics Market Regional Analysis/Insights
The global STD diagnostics market is analysed and market size insights and trends are provided by country, type, testing, testing devices and end-user as mentioned above.
The countries covered in the global STD diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global STD diagnostics market due to the availability of FDA-approved advanced sexually transmitted diseases testing devices and presence of public healthcare insurance plans fostering healthcare consciousness among population
Asia-Pacific is expected to grow at the highest growth rate in the global STD diagnostic market, during the forecast period of 2023 to 2030 owing to due to economic prosperity and the prevalence of sexually transmitted infections in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global STD diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global STD diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global STD diagnostics market. The data is available for historic period 20105-2020.
Competitive Landscape and Global STD Diagnostics Market Share Analysis
The global STD diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global STD diagnostics market.
Some of the major players operating in the global STD diagnostics market are:
- Abbott (U.S.)
- BD (U.S.)
- Biocartis (Belgium)
- bioMérieux SA (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Cepheid (U.S.)
- Danaher (U.S.)
- DiaSorin(Italy)
- GenMark Diagnostics, Inc. (U.S.)
- Hologic Inc. (U.S.)
- OraSure Technologies, Inc. (U.S.)
- Qualigen Inc(U.S.)
- Quidel Corporation(U.S.)
- F. Hoffmann-La Roche Ltd (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- MedMira Inc. (U.S.)
SKU-